Ho PW, Chang EE, Leung CT, Liu H, Malki Y, Pang SY, Choi ZY, Liang Y, Lai WS, Ruan Y, Leung KM, Yung S, Mak JC, Kung MH, Ramsden DB, Ho SL. Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects. NPJ Parkinsons Dis. 2022 Sep 10;8(1):115. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. DNL151